CIPOLLI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 1.794
NA - Nord America 1.614
AS - Asia 1.217
SA - Sud America 192
AF - Africa 30
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.852
Nazione #
US - Stati Uniti d'America 1.577
RU - Federazione Russa 804
SG - Singapore 444
CN - Cina 438
GB - Regno Unito 358
BR - Brasile 149
IT - Italia 129
VN - Vietnam 105
HK - Hong Kong 104
SE - Svezia 99
DE - Germania 86
FR - Francia 83
IE - Irlanda 75
FI - Finlandia 72
KR - Corea 42
CA - Canada 18
AR - Argentina 16
BE - Belgio 16
JP - Giappone 16
MX - Messico 14
ES - Italia 13
ID - Indonesia 13
IN - India 13
NL - Olanda 13
ZA - Sudafrica 13
EC - Ecuador 12
UA - Ucraina 12
BD - Bangladesh 10
PL - Polonia 9
TR - Turchia 9
AT - Austria 8
PY - Paraguay 6
BJ - Benin 5
AU - Australia 4
CH - Svizzera 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
LT - Lituania 3
PK - Pakistan 3
TG - Togo 3
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
IQ - Iraq 2
MA - Marocco 2
UY - Uruguay 2
UZ - Uzbekistan 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
YT - Mayotte 1
Totale 4.852
Città #
Southend 303
Dallas 284
Moscow 275
Chandler 248
Singapore 198
Ashburn 144
Beijing 106
Hong Kong 103
Woodbridge 91
Ann Arbor 87
Dublin 75
Jacksonville 58
New York 45
Houston 44
The Dalles 44
Verona 40
Helsinki 39
Los Angeles 37
Nanjing 36
Ho Chi Minh City 29
Munich 29
Lawrence 28
Princeton 28
Jinan 27
Shenyang 24
Seoul 23
Wilmington 22
Buffalo 21
Hanoi 19
Tokyo 15
Brussels 14
Hebei 14
Santa Clara 14
São Paulo 14
Changsha 13
Milan 13
Dong Ket 11
Amsterdam 10
Columbus 10
Redondo Beach 10
Taizhou 10
Turku 10
Denver 9
Jakarta 9
Johannesburg 9
Nanchang 9
Ningbo 9
Stockholm 9
Ankara 8
Boardman 8
Bologna 8
Chicago 8
Haikou 8
Tianjin 8
Warsaw 8
Chennai 7
London 7
Montreal 7
Sindelfingen 7
Zhengzhou 7
Council Bluffs 6
Falkenstein 6
Ferrara 6
Jiaxing 6
Norwalk 6
San Francisco 6
Seattle 6
Vienna 6
Asunción 5
Atlanta 5
Brooklyn 5
Cotonou 5
Falls Church 5
Frankfurt am Main 5
Guangzhou 5
Hangzhou 5
Lanzhou 5
Lappeenranta 5
Redwood City 5
Taiyuan 5
Auburn Hills 4
Boston 4
Hải Dương 4
Mexico City 4
Nuremberg 4
Osasco 4
Ottawa 4
Piracicaba 4
Rio de Janeiro 4
Washington 4
Can Tho 3
Dearborn 3
Dhaka 3
Dundee 3
Düsseldorf 3
Fuzhou 3
Guayaquil 3
Lomé 3
Manaus 3
Miami 3
Totale 2.988
Nome #
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. 273
Further characterization of Shwachman-Diamond syndrome: psychological functioning and quality of life in adult and young patients. 167
Further Insights into the Hematological Disorders Observed in Shwachman-Diamond Syndrome: mTOR and STAT3 Hyper-Phosphorylation in CD4+ and CD8+ T Cells and Efficacy of Rapamycin Treatment 162
Ataluren-driven Restoration of Shwachman-Bodian-Diamond Syndrome Protein Function in Shwachman-Diamond Syndrome Bone Marrow Cells 161
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 154
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. 153
Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. 151
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 151
Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome 149
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series 148
Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. 146
Identification of novel mutations in patients with Shwachman-Diamond syndrome 141
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome 139
291 Colon cancer screening program in adult CF patients: an Italian cross-sectional pilot study 137
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 137
A Prospective Haematological Survey Of Italian Patients Affected By Shwachman-Diamond Syndrome: Results Of A Ten Years Multicentric Study 135
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 132
GENETIC ANALYSIS OF THE SBDS GENE AMONG NON-ITALIAN PATIENTS 132
A Prospective Study of Hematologic Complications and Long-Term Survival of Italian Patients Affected by Shwachman-Diamond Syndrome 131
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 128
Shwachman-Diamond syndrome 128
Celiac disease and obesity: need for nutritional follow-up after diagnosis. 116
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 115
Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability 114
Novel Translational Read-Through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome 114
Mutation Screening of Elongation Factor 2 in Shwachman-Diamond Syndrome Patients Lacking Mutations in the SBDS Gene 112
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 112
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 108
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 106
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 105
Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old 105
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 103
Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond Syndrome carrying biallelic SBDS mutations 98
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes 82
Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia 77
Efficacy of Elexacaftor–Tezacaftor–Ivacaftor on chronic rhinosinusitis in cystic fibrosis 77
Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients 75
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 71
The Gluten Free Diet's Impact on Growth in Children with Celiac Disease in Two Different Countries 70
Totale 4.915
Categoria #
all - tutte 16.104
article - articoli 14.864
book - libri 0
conference - conferenze 1.240
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 17 4 10 2 5 23 27
2021/2022210 11 75 1 11 7 3 4 15 7 6 17 53
2022/2023587 32 81 42 113 48 134 4 32 68 8 15 10
2023/2024307 9 23 21 37 33 47 11 32 7 28 42 17
2024/2025852 34 30 36 164 36 33 44 32 150 38 71 184
2025/20261.967 146 155 314 510 685 157 0 0 0 0 0 0
Totale 4.915